Int Arch Otorhinolaryngol 2014; 18 - a2282
DOI: 10.1055/s-0034-1388784

Quality of Life and Hearing Thresholds in Oncology Patients

Priscila Feliciano de Oliveira 1, Daniela de Arimatéia Rosa Santos 1, Gregorina Silva Ribeiro Rocha 1, Izabella Moura de Azevedo Souza 1, Maria Angélica dos Santos Souza 1, Tâmara Figueirêdo do Carmo Santos 1
  • 1Universidade Federal de Sergipe

Introduction: The evaluation of quality of life (QoL) assesses patients' well-being by taking into account physical, psychological, and social conditions. Cancer and its treatment result in severe biochemical and physiological alterations associated with a deterioration of QoL. One of the physiological damages is the hearing loss, which can cause communication difficulty.

Objective: The aim of this study was to assess the QoL and hearing thresholds in oncology patients.

Method: Overall 76 cancer patients, with ages ranging from 25 to 60 years, were recruited during the treatment. It was used a self-assessment approach, European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) and a conventional pure tone audiometry. Statistical analysis was performed (t-test) with a significance level of 95% (p < 0.05).

Results: Overall 34.5% of the participants had hearing loss characterized by high frequencies (4.6 and 8 kHz). The global health status and functional scale had a high average (69.36/51.57) therefore, the symptoms scale were lower (36.22) than the others. There was no significant difference between QoL status regarding hearing loss (global and symptoms p = 0.08; functional p = 0.27). They reported tinnitus (57.7%) but there was a negative correlation between QoL (global p = 0.84; functional p = 0.69; symptoms p = 0.28). There was no significant difference between the stage of cancer treatment (middle or final) regarding global status (p = 0.86), functional scale (p = 0.51), and symptoms (p = 0.22).

Conclusion: The patients had a good QoL in spite of having cancer, but they had hearing loss.